Home | Welcome to Contract Pharma   
Last Updated Sunday, April 26 2015

Print RSS Feed

Search Results for 'Financial Report: AMRI'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published February 12, 2015
Contract revenue up 35% in the quarter Read More »
Published November 7, 2014
Contract revenue up 8% in the quarter Read More »
Published November 6, 2013
Contract revenue up 16% in the quarter Read More »
Published August 6, 2013
Revenues up 19% in the quarter Read More »
Published November 6, 2012
Large-scale manufacturing revenue up 14% Read More »
By Gil Roth
Published May 9, 2012
Hungary closure leads to charges Read More »
Published May 5, 2008
AMRI 1Q Revenues: $53.6 million (+11%) 1Q Earnings: $4.7 million (+47%) Comments: Total contract revenue increased to $45.3 million in the quarter (+10%).  Discovery Services revenue was $13.3 million (+34%). Development and Small Scale… Read More »
Published February 11, 2008
AMRI 4Q Revenues: $47.2 million (+1%) 4Q Loss: $844,000 (loss of $764,000 in 4Q2006) FY Revenues: $192.5 million (+7%) FY Earnings: $8.9 million (earnings were $2.2 million FY2006) Comments: Total contract and milestone revenue for th… Read More »
Published May 9, 2006
Merck has announced a pair of acquisitions. The company will acquire Santa Clara, CA-based Abmaxis, Inc. for $80 million in cash. Abmaxis is known for its antibody engineering technology platform, Abmaxis in-silico Immunization (AISIM), which enables… Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On